Showing results (131-140 of 182) with videos related to
Sort By:
Pageof 19
Clinical Neurophysiology Practice|October 27, 2025
Home-Based sensing of the nervous system with clinical neurophysiology technologies: IFCN handbook chapterChristian Sandøe Musaeus, Pedro F Viana, Mark Cook, et al.Journal of Clinical Pharmacology|July 11, 2025
Characterizing Cellular Expansion of Idecabtagene Vicleucel and Association with Clinical Efficacy and Safety in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple MyelomaFan Wu, Xirong Zheng, Joseph Burnett, et al.Nature Reviews. Nephrology|February 22, 2012
Novel approaches for reducing free light chains in patients with myeloma kidneyColin A Hutchison, Joan Bladé, Paul Cockwell, et al.Blood Advances|November 24, 2020
Renal outcome in patients with newly diagnosed multiple myeloma: results from the UK NCRI Myeloma XI trialRitika Rana, Paul Cockwell, Mark Drayson, et al.European Journal of Haematology|August 8, 2015
Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injuryPunit Yadav, Colin A Hutchison, Kolitha Basnayake, et al.Haematologica|May 13, 2010
CD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effectAndrew McLarnon, Karen P Piper, Oliver C Goodyear, et al.Epilepsia|August 28, 2020
A new era in electroencephalographic monitoring? Subscalp devices for ultra-long-term recordingsJonas Duun-Henriksen, Maxime Baud, Mark P Richardson, et al.Journal of Clinical Pathology|September 30, 2010
Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidneyKolitha Basnayake, Chee Kay Cheung, Michael Sheaff, et al.Eclinicalmedicine|May 13, 2020
Anti-seizure therapy with a long-term, implanted intra-cerebroventricular delivery system for drug-resistant epilepsy: A first-in-man studyMark Cook, Michael Murphy, Kristian Bulluss, et al.British Journal of Haematology|February 3, 2009
Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myelomaRakesh Popat, Heather Oakervee, Catherine Williams, et al.Pageof 19